Vision Financial Markets’s ADMA Biologics ADMA Stock Holding History

Vision Financial Markets’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.6K	Sell	2,975 -25	-0.8%	-$228	0.02%	178
2026 Q1	$27K	Hold	3,000	–	–	0.03%	154
2025 Q4	$54.7K	Hold	3,000	–	–	0.06%	109
2025 Q3	$44K	Hold	3,000	–	–	0.04%	143
2025 Q2	$54.6K	Hold	3,000	–	–	0.05%	123
2025 Q1	$59.5K	Hold	3,000	–	–	0.06%	104
2024 Q4	$51.5K	Buy	+3,000	New	+$56.4K	0.06%	112

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Vision Financial Markets's ADMA Position: Q2 2026 in Review

Vision Financial Markets reduced its ADMA Biologics (ADMA) stake by 0.83% in Q2 2026, selling an estimated $228 and leaving 2,975 shares worth $25.6K. The position accounts for 0.02% of the portfolio, ranked #178.

Vision Financial Markets first reported a position in ADMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $59.5K in Q1 2025. 72 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Vision Financial Markets held 2,975 shares of ADMA Biologics worth $25.6K as of Q2 2026.
Vision Financial Markets sold 25 ADMA Biologics shares in Q2 2026, an estimated $228.
ADMA Biologics made up 0.02% of Vision Financial Markets's portfolio in Q2 2026, its #178 holding.
Vision Financial Markets first reported a position in ADMA Biologics in Q4 2024 and has held it in 7 quarters since.
Vision Financial Markets's ADMA Biologics position peaked at $59.5K in Q1 2025.
72 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.